No reported Insider Trades available for EBISU GLOBAL OPPORTUNITIES FUND LIMITED in the Trendlyne database.
EBISU GLOBAL OPPORTUNITIES FUND LIMITED's has made SAST transactions in Balaxi Pharmaceuticals Ltd. recently where a Sale of 500,000 Equity shares done . Disclosure was reported to the exchange on June 6, 2025.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Balaxi Pharma | EBISU Global Opportunities Fund Limited | Sale | 09 Jun 2025 | 500,000 | 2,675,137 (0%) | - | - | 02 Jun 2025 03 Jun 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | ||
Balaxi Pharma | EBISU Global Opportunities Fund Limited | Sale | 03 May 2025 | 1,345,891 | 3,175,137 (0%) | - | - | 19 Mar 2025 24 Apr 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | ||
Balaxi Pharma | EBISU Global Opportunities Fund Limited | Acquisition | 03 May 2025 | 4,521,028 | 4,521,028 | - | - | 03 Mar 2025 03 Mar 2025 |
SAST (Reg29(1)) | Equity shares | Open Market | ||
Balaxi Pharma | EBISU Global opportunities fund limited | Acquisition | 06 Mar 2025 | 4,521,028 | 4,521,028 | - | - | 03 Mar 2025 03 Mar 2025 |
SAST (Reg29(1)) | Equity shares | Open Market |